Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Revenue (2016 - 2023)

Aethlon Medical filings provide 13 years of Revenue readings, the most recent being $574245.0 for Q1 2023.

  • On a quarterly basis, Revenue rose 4278.2% to $574245.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $574245.0, a 95.21% increase, with the full-year FY2023 number at $574245.0, up 95.21% from a year prior.
  • Revenue hit $574245.0 in Q1 2023 for Aethlon Medical, up from $13116.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $624871.0 in Q4 2020 to a low of $13116.0 in Q1 2022.
  • Median Revenue over the past 5 years was $131966.0 (2021), compared with a mean of $205245.5.
  • Biggest five-year swings in Revenue: crashed 97.26% in 2021 and later skyrocketed 4278.2% in 2023.
  • Aethlon Medical's Revenue stood at $413458.0 in 2019, then surged by 51.13% to $624871.0 in 2020, then crashed by 97.26% to $17117.0 in 2021, then fell by 23.37% to $13116.0 in 2022, then skyrocketed by 4278.2% to $574245.0 in 2023.
  • The last three reported values for Revenue were $574245.0 (Q1 2023), $13116.0 (Q1 2022), and $17117.0 (Q4 2021) per Business Quant data.